Sarepta Therapeutics Inc (NASDAQ:SRPT)

76.40
Delayed Data
As of Apr 24
 -1.91 / -2.44%
Today’s Change
28.82
Today|||52-Week Range
84.37
+37.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-135.8M-220.0M-267.3M-50.7M
 
 
 
 
 
Depreciation3.7M5.2M5.6M8.1M
 
 
 
 
 
Total Other Cash Flow25.7M33.3M31.6M-91.9M
 
 
 
 
 
Funds From Operations-106.4M-181.5M-230.1M-134.5M
 
 
 
 
 
Funds From/For Other Operating Expenses22.1M-32.0M15.8M97.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-128.5M-149.5M-245.8M-232.0M
 
 
 
 
 
 
InvestingIncrease In Investments-274.4M-172.7M-195.4M-589.5M
 
 
 
 
 
Decrease In Investments142.2M185.9M112.1M306.9M
 
 
 
 
 
Capital Expenditures-25.4M-3.4M-5.3M-12.0M
 
 
 
 
 
Other Investing - Sources------125.0M
 
 
Net Cash Flow Investing-159.0M8.4M-90.2M-178.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.0019.6M0.0054.6M
 
 
 
Long Term Debt Reduction-94.0K-2.6M-7.6M-54.8M
 
 
 
 
 
Net Proceeds Stock Sale104.2M130.8M385.7M369.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.00570.0M
 
 
Other Uses - Financing0.000.000.0050.9M
 
 
Net Cash Flow - Financing104.2M147.8M378.1M888.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-183.4M6.8M42.1M477.3M